Tag Archives: Added

NILL added new content to the Indian Law Bulletins on 7/12

Law Review & Bar Journal Bulletinhttp://www.narf.org/nill/bulletins/lawreviews/2018.htmlAmerican colonialism and constitutional redemption. An analysis of the lack of protection for intangible tribal cultural property in the digital age.The Trump public lands revolution: Redefining "the public" in public land law. Global water crisis … Continue reading

Posted in Law Librarians | Tagged , , , , , | Leave a comment

NILL added new content to the Indian Law Bulletins on 7/6

Law Review & Bar Journal Bulletinhttp://www.narf.org/nill/bulletins/lawreviews/2018.htmlThe potential effects of Strugeon v. Frost on Alaska Native corporations. Federal Indian Law — First Circuit Court of Appeals clarifies Penobsoct Nation's reservation boundary — Penobscot Nation v. Mills, 861 F.3D 324 (1st Cir. … Continue reading

Posted in Law Librarians | Tagged , , , , | Leave a comment

NILL added new content to the Indian Law Bulletins on 6/22

U.S. Supreme Court Bulletin http://www.narf.org/nill/bulletins/sct/2017-2018update.html Read the latest Tribal Supreme Court Project update published on 6/20/18. Law Review & Bar Journal Bulletinhttp://www.narf.org/nill/bulletins/lawreviews/2018.htmlThrough a Federal Habeas Corpus glass, darkly- Who is entitled to effective assistance of counsel in tribal court under … Continue reading

Posted in Law Librarians | Tagged , , , , , | Leave a comment

Rexulti Warnings For Compulsive Behavior And Impulse Control Problems Added To Drug Label

FDA: Patients Using Rexulti At Risk For Experiencing Intense Urges For Gambling And Inability To Control Conduct   (Posted by Tom Lamb at DrugInjuryWatch.com)   Rexulti® (brexpiprazole) was initially approved by the FDA in 2015 for the adjunctive treatment of … Continue reading

Posted in Health Law | Tagged , , , , , , , , , | Leave a comment

Gadolinium Retention Warnings Added To Drug Labels For Gadolinium Contrast Agents Used During MRI / MRA

Label Changes Announced By FDA In December 2017 Finally Approved For Magnevist, Omniscan, And Other GBCAs In April 2018   (Posted by Tom Lamb at DrugInjuryWatch.com)   Gadolinium based contrast agents (GBCAs) are substances that are injected into patients during … Continue reading

Posted in Health Law | Tagged , , , , , , , , , | Leave a comment